Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RISPERDAL CONSTA
- Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
- Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia
- An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder
- Bioavailability of LY03004 and Risperdal® Consta®
- An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia
- Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia
- Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate
- A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
- A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia
- An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder
- Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.
- Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia
- Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia
- Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?
- High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone
- An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment
- RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
- Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence
- A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode
- Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis
- Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
- Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
- Risperdal Consta and Health Care Utilization in Patients With Schizophrenia
- Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia
- A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder
- A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)
- A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication
- A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis
- A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder
- Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)
- Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-ac
- Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder
- Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode
- A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)
- A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres
- A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
- Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence
- A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia
- Risperdal Consta for Bipolar Disorder
- Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia
- A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes
- Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
- A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.
- Switching Medication to Treat Schizophrenia
Clinical trials list
click for details